CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-21 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,775 | 1,775 | ||
| 2024-10-21 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +1,145 | 74,622 | ||
| 2024-10-21 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −608 | $120.76 | $73K | 74,014 |
| 2024-10-21 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,145 | 1,145 | ||
| 2024-10-20 | Sheena Jonathan Director | Exercise or conversion 10b5-1 | +190 | 282,231 | ||
| 2024-10-20 | Sheena Jonathan Director | Exercise or conversion · Restricted Stock Unit 10b5-1 | −190 | 952 | ||
| 2024-10-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion 10b5-1 | +856 | 207,256 | ||
| 2024-10-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −856 | 4,280 | ||
| 2024-10-20 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion 10b5-1 | +3,386 | 194,549 | ||
| 2024-10-20 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion · Restricted Stock Unit 10b5-1 | −3,386 | 16,930 | ||
| 2024-10-20 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +1,522 | 73,477 | ||
| 2024-10-20 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,522 | 7,609 | ||
| 2024-10-15 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −4,523 | $130.40 | $590K | 191,163 |
| 2024-10-01 | Sheena Jonathan Director | Sale 10b5-1 | −876 | $124.82 | $109K | 283,865 |
| 2024-10-01 | Sheena Jonathan Director | Sale 10b5-1 | −1,397 | $125.83 | $176K | 282,468 |
| 2024-10-01 | Sheena Jonathan Director | Sale 10b5-1 | −427 | $126.42 | $54K | 282,041 |
| 2024-10-01 | Sheena Jonathan Director | Sale 10b5-1 | −771 | $125.23 | $97K | 58,161 |
| 2024-10-01 | Sheena Jonathan Director | Sale 10b5-1 | −729 | $126.27 | $92K | 57,432 |
| 2024-10-01 | Sheena Jonathan Director | Sale 10b5-1 | −475 | $124.89 | $59K | 58,457 |
| 2024-10-01 | Sheena Jonathan Director | Sale 10b5-1 | −1,025 | $125.95 | $129K | 57,432 |
Page 66 of 85 · 1,682 trades